ANG Lifesciences India Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-124.13	-101.43	-2.62	403.17	70.28
Depreciation & Amortization	62.7	83.71	93.54	58.75	13.17
Loss (Gain) From Sale of Assets	-	-	-8.44	1.06	-
Provision & Write-off of Bad Debts	4.52	10.95	9.76	21.37	-
Other Operating Activities	-7.86	-35.51	106.4	213.35	28.97
Change in Accounts Receivable	62.86	114.22	179.31	-452.18	-126.79
Change in Inventory	-63.43	7.21	-115.28	-177	-92.54
Change in Accounts Payable	-5.92	-44.03	-22.21	253.31	142.51
Change in Other Net Operating Assets	68.7	-130.08	23.33	-74.65	55.85
Operating Cash Flow	-2.56	-94.95	263.77	247.17	91.44
Operating Cash Flow Growth	-	-	6.72%	170.31%	89.29%
Capital Expenditures	-37.51	-55.69	-104.45	-413.45	-42.44
Sale of Property, Plant & Equipment	-	244.96	-	-	-
Investment in Securities	19.38	4.37	4.53	-34.34	-35
Other Investing Activities	2.26	5.28	6.67	3.68	0.49
Investing Cash Flow	-15.87	198.92	-93.25	-444.1	-76.95
Short-Term Debt Issued	55.58	53.97	-	175.14	-
Long-Term Debt Issued	56.3	-	-	114.08	39.55
Total Debt Issued	111.88	53.97	-	289.22	39.55
Short-Term Debt Repaid	-	-	-16.56	-	-
Long-Term Debt Repaid	-11.31	-51.59	-56.69	-	-21.76
Total Debt Repaid	-11.31	-51.59	-73.25	-	-21.76
Net Debt Issued (Repaid)	100.57	2.38	-73.25	289.22	17.79
Issuance of Common Stock	-	-	20	-	-
Common Dividends Paid	-	-	-	-10.35	-
Other Financing Activities	-83.75	-106.4	-117.49	-79.59	-29.66
Financing Cash Flow	16.82	-104.03	-170.74	199.28	-11.86
Net Cash Flow	-1.61	-0.06	-0.22	2.35	2.62
Free Cash Flow	-40.07	-150.63	159.33	-166.28	49
Free Cash Flow Growth	-	-	-	-	53.66%
Free Cash Flow Margin	-4.32%	-10.31%	7.25%	-4.69%	3.17%
Free Cash Flow Per Share	-3.07	-11.54	12.26	-12.83	3.78
Cash Interest Paid	83.75	106.4	117.49	79.59	29.66
Cash Income Tax Paid	42.27	134.1	34.59	5.27	31.8
Levered Free Cash Flow	-35.87	-211.96	92.18	-206.34	-197.58
Unlevered Free Cash Flow	19.63	-147.45	162.13	-154.59	-178.37
Change in Working Capital	62.21	-52.68	65.15	-450.53	-20.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.